Code Snippets
curl "https://financialdata.net/api/v1/senate-trading?identifier=DHR&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/senate-trading?identifier=DHR&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/senate-trading?identifier=DHR&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"name_of_reporting_person": "Alan Armstrong",
"type_of_reporting_person": "Senator",
"report_date": "2026-07-21",
"transaction_number": "87",
"transaction_type": "Purchase",
"transaction_date": "2026-03-27",
"owner_type": "Self",
"trading_symbol": "DHR",
"asset_name": "Danaher Corporation Common Stock",
"asset_type": "Stock",
"amount": "$1,001 - $15,000",
"comment": null
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security. (e.g., MSFT) |
| offset | integer | (Optional) The initial position of the record subset, which indicates how many records to skip. Defaults to 0. (e.g., 100) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
Members of the United States Senate are required to disclose any purchase, sale, or exchange of a stock, bond, commodity future, or other security when the transaction exceeds $1,000. The API endpoint provides detailed data about each of the transactions made. There is a limit of 100 records per API call.
Company Profile
DANAHER CORP /DE/
NYSE: DHR- Market Cap:$125.90B
- ISIN:US2358511028
- Fiscal Year End:12/31
- CEO:Rainer Blair
- Employees:63000
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.